-
HER2-Low Gastric / Gastroesophageal Junction (GEJ) Adenocarcinoma | Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2034
$6,989.00 – $20,967.00Select optionsAccording to Mellalta Meets Analyst’s most recent estimate, the HER2-Low Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma therapeutics market was worth US$ Billion in 2023 and is predicted to grow at a XX% CAGR to reach US$ Billion by 2034.
-
HER2-Low Metastatic Breast Cancer –Tumour Deck
$11,800.00 – $20,000.00Select optionsThe research study conducted by Mellalta Meets provides insights into the HER2-Low Metastatic Breast Cancer market dynamics, treatment trends, and key opportunities in the G7 regions. It highlights the need for novel targeted therapies, the potential of biomarker strategies, and the significant market opportunity for drug developers targeting the HER2-Low population. The study serves as a comprehensive resource for understanding the current landscape and future prospects of HER2-Low mBC treatment.
-
HER2-Low Breast Cancer– Pipeline Analytics 2023
$2,500.00 – $7,500.00Select optionsThe 2023 Mellalta Meets report analyzes the HER2-Low Breast Cancer Therapies pipeline, highlighting the market opportunities and competitive landscape with over 30 companies developing pipeline drug profiles. The study marks a significant shift in breast cancer understanding, indicating over 50% of such cancers as HER2-low, thereby creating new prospects for therapeutic ADCs in treating HER2-low tumors. It also details the promising development pipeline involving a variety of ADCs and combination strategies to address this newly classified breast cancer subtype.
-
HER2-Low Metastatic Breast Cancer (mBC) | Primary Research (KOL’s Insight) | Market Intelligence | Epidemiology & Market Forecast-2034
$6,989.00 – $20,967.00Select optionsAccording to Mellalta Meets Analyst’s most recent estimate, the HER2-Low Metastatic Breast Cancer therapeutics market was worth US$ Billion in 2023 and is predicted to grow at a XX% CAGR to reach US$ Billion by 2034.
Call us today: +1 (304) 470-2225
English
You can use WPML or Polylang and their language switchers in this area.
